Peak XV Companions bought 5,721,378 shares, or 57.21 lakh shares, in Go Digit Basic Insurance at Rs 243 apiece on Wednesday, July 29, in line with alternate deal information.

The sale, executed by way of Peak XV Partners Progress Investments III, was valued at Rs 139.03 crore and represented roughly 0.62% of Go Digit’s excellent fairness. ICICI Prudential Mutual Fund acquired all of the shares bought within the transaction.

The deal was Peak XV’s second disclosed sale of Go Digit shares in lower than two months. On June 4, the investment agency bought 3,333,500 shares at Rs 300 every for about Rs 100 crore. Aditya Birla Solar Life Mutual Fund purchased 2,166,667 shares, whereas JPMorgan (Taiwan) Jap Know-how Fund acquired 1,166,833 shares.

Throughout the 2 transactions, Peak XV bought a mixed 9,054,878 shares, equal to 90.55 lakh shares, for combination consideration of roughly Rs 239.03 crore.

Go Digit studies decrease statutory revenue and premium

Go Digit was included in December 2016 underneath the title Oben Basic Insurance coverage Restricted. It adopted its current title in June 2017 and obtained its registration from the Insurance coverage Regulatory and Improvement Authority of India on September 20, 2017.

The insurer provides motor, well being, journey, property, marine and legal responsibility insurance coverage, amongst different non-life merchandise. Motor remained its largest phase by internet premium earned within the quarter ended June 2026, adopted by well being and private accident insurance coverage.

Below the statutory insurance-accounting format included in its alternate submitting, Go Digit’s PAT fell 37.5% to Rs 86.39 crore within the first quarter of 2026-27, from Rs 138.33 crore a yr earlier. Gross written premium declined 8.4% to Rs 2,730.86 crore from Rs 2,981.80 crore.

The corporate individually launched monetary info underneath Indian Accounting Requirements, or Ind AS, displaying PAT of Rs 372 crore, up from Rs 325 crore a yr earlier. Its “PAT solely with deferred acquisition price” measure was Rs 190 crore, in contrast with Rs 200 crore within the corresponding quarter.

These revenue figures use totally different accounting shows and shouldn’t be in contrast with each other with out accounting for the variations in recognition, measurement and deferred acquisition-cost therapy.